Position in EXEL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,185,397
+$265,268 QoQ
Shares Held
74,269
+11.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sanctuary Advisors, LLC holds $85,126,148 across 54 Biotechnology names. EXEL ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,631 | $31,393,135 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,360 | $22,041,214 | |
| 3 | INSM |
INSMED Inc
|
23,969 | $3,919,410 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
74,269 | $3,185,397 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
94,996 | $2,352,100 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,839 | $1,931,949 | |
| 7 | ARGX |
Argenx SE
|
2,432 | $1,775,968 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
27,324 | $1,713,214 |
All Filings in EXEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,185,397 | 74,269 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,920,129 | 66,624 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,276,624 | 30,911 | Shares | Sole | 2026-01-13 | |
| 2025-06-30 | $710,437 | 16,117 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $1,363,271 | 36,925 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $2,379,085 | 71,444 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,018,822 | 39,261 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $618,014 | 27,504 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||